0000000001084972

AUTHOR

Marco Roberto

showing 2 related works from this author

Heart rate variability in sick sinus syndrome: does it have a diagnostic role?

2019

BACKGROUND: Hypothesis of our study was that the irregular rhythm of sick sinus syndrome (SSS) was characterized by an augmented HRV. Objective was to assess whether SSS patients had a typical HRV profile. METHODS: We screened all 1947 consecutive Holter ECGs performed in our Units of Vascular Medicine and Internal Medicine and Cardioangiology at the University of Palermo (Italy) from April 2010 to September 2014. Among these, we selected 30 patients with ECG criteria of SSS. They were compared to 30 patients without SSS matched for age, sex and comorbidities. RESULTS: The SSS group had a lower mean heart rate (HR) (P=0.003), and a longer mean NN max-min longer (P<0.0005) compared to con…

Malemedicine.medical_specialtySettore MED/09 - Medicina Interna030204 cardiovascular system & hematologySick sinus syndrome03 medical and health sciences0302 clinical medicineHeart RatePredictive Value of TestsInternal medicineHeart ratemedicineHeart rate variabilityHumans030212 general & internal medicineAgedRetrospective StudiesAged 80 and overSick Sinus Syndromemedicine.diagnostic_testbusiness.industryRetrospective cohort studyMiddle Agedmedicine.diseaseSSS*ItalyHolter ECG HR SDNNi HRVPredictive value of testsCase-Control StudiesAmbulatoryCardiologyElectrocardiography AmbulatoryFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyMinerva cardioangiologica
researchProduct

Old and New Drugs for Treatment of Advanced Heart Failure.

2020

Background: Advanced heart failure (HF) is a progressive disease with high mortality and limited medical therapeutic options. Long-term mechanical circulatory support and heart transplantation remain goldstandard treatments for these patients; however, access to these therapies is limited by the advanced age and multiple comorbidities of affected patients, as well as by the limited number of organs available. Methods: Traditional and new drugs available for the treatment of advanced HF have been researched. Results: To date, the cornerstone for the treatment of patients with advanced HF remains water restriction, intravenous loop diuretic therapy and inotropic support. However, many patien…

Inotropemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineFurosemideDrug DiscoverymedicineHumansDecompensation030212 general & internal medicine: Dobutamine dopamine nitroglycerine sodium nitroprusside vaptans ivabradineIntensive care medicineDiureticsSimendanPharmacologyHeart transplantationHeart Failurebusiness.industryLevosimendanLoop diureticmedicine.diseasePrognosisOmecamtiv mecarbilIstaroximeHeart failurebusinessmedicine.drugCurrent pharmaceutical design
researchProduct